Genetic predictors of antipsychotic-induced weight gain: A case-matched multi-gene study

Journal of Central South University (Medical Sciences)

Volumn 36, Issue 8, 2011, Pages 720-723

  Wu, Renrong ^a   Zhao, Jingping ^a   Shao, Ping ^a   Ou, Jianjun ^a   Chang, Maihui ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

Adiponectin; Antipsychotic; Gene; HTR2C; Leptin; Schizophrenia; Weight gain

Indexed keywords

ADIPONECTIN; LEPTIN; NEUROLEPTIC AGENT; SEROTONIN 2C RECEPTOR;

ADOLESCENT; ADULT; ARTICLE; BODY MASS; CASE CONTROL STUDY; DRUG EFFECT; FEMALE; GENETIC POLYMORPHISM; GENETICS; HUMAN; MALE; MIDDLE AGED; PATHOPHYSIOLOGY; SCHIZOPHRENIA; WEIGHT GAIN;

ADIPONECTIN; ADOLESCENT; ADULT; ANTIPSYCHOTIC AGENTS; BODY MASS INDEX; CASE-CONTROL STUDIES; FEMALE; HUMANS; LEPTIN; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; RECEPTOR, SEROTONIN, 5-HT2C; SCHIZOPHRENIA; WEIGHT GAIN; YOUNG ADULT;

EID: 80053377815     PISSN: 16727347     EISSN: None     Source Type: Journal    
DOI: 10.3969/j.issn.1672-7347.2011.08.003     Document Type: Article

References (16)

1. Bernstein J G. Induction of obesity by psychotropic drugs[J]. Ann N Y Acad Sci, 1987, 499: 203-215.
2. Umbricht D S, Pollack S, Kane J M. Clozapine and weight gain[J]. J Clin Psychiatry, 1994, 55: 157-160. (Pubitemid 24353043)
3. Melkersson K. Clozapine and olanzapine, but not conventional antipsychotics, increase insulin release in vitro[J]. Eur Neuropsychopharmacol, 2004,14(2): 115-119. (Pubitemid 38175428)
4. Chrome L L. The increase in risk of diabetes mellitus from exposure to second-generation antipsychotic agents [J]. Drugs Today (Bare), 2004, 40(5):445-464.
5. Reynolds G P, Zhang Z J, Zhang X B. Association of antipsychotic drug-induced weight gain with a 5-HT2C receptor gene polymorphism[J]. Lancet, 2002, 359(9323): 2086-2087. (Pubitemid 34680975)
6. Yuan X, Yamada K, Ishiyama-shigemoto S, et al. Identification of polymorphic loci in the promoter region of the serotonin 5-HT2C receptor gene and their association with obesity and type II diabetes[J]. Diabetologia, 2000, 43(3): 373-376. (Pubitemid 30163481)
7. Melkersson K I, Hulting A L, Brismar K E. Elevated levels of insulin, leptin, and blood lipids in olanzapine-treated patients with schizophrenia or related psychoses[J]. J Clin Psychiatry, 2000, 61(10): 742-749.
8. Richards A A, Hickman I J, Wang A Y, et al. Olanzapine treatment is associated with reduced high molecular weight adiponectin in serum: a potential mechanism for olanzapine-induced insulin resistance in patients with schizophrenia [J]. J Clin Psychopharmacol, 2006, 26(3) : 232-237. (Pubitemid 43804614)
9. Hoffstedt J, Eriksson P, Mottagui-tabar S, et al. A polymorphism in the leptin promoter region (-2548G/a) influences gene expression and adipose tissue secretion of leptin [J]. Horm Metab Res, 2002, 34(7) : 355-359.
10. Menzaghi T C. A haplotype at the adiponectin locus is associated with obesity and other features of the insulin resistance syndrome[J]. Diabetes, 2002, 57(7) : 2306.
11. American Psychiatric Association. Diagnostic and statistical manual of mental disorders [M]. 4 th ed. Washington, DC : APA, 1994.
12. Wu R R, Zhao J P, Jin H, et al. Lifestyle intervention and metformin for treatment of antipsychotic-induced weight gain:a randomized controlled trial[J]. JAMA, 2008, 299(2) : 185-193.
13. Zhang YY, Proece R, Maffei M, et al. Positinal cloning of the mouse obese gene and its human homologue [J]. Nature, 1994, 372(6505):425-432.
14. Scherer P E, Williams S, Fogliano M, et al. A novel serumprotein similar to C1 q, produced exclusively in adipocytes[J]. J Biol Chem, 1995, 270(45) : 26746-26749.
15. Hong C J, Lin C H, Yu Y W, et al. Genetic variant of the histamine-1 receptor (glu349asp) and body weight change during clozapine treatment[J]. Psychiatr Genet, 2002, 12(3): 169-171. (Pubitemid 35316205)
16. Wirshing D A, Wirshing W C, Kysar L, et al. Novel antipsychotics: comparison of weight gain liabilities[J]. J Clin Psychiatry, 1999, 60(6): 358-363. (Pubitemid 29289721)